Diametric Capital, LP Evolus, Inc. Transaction History

Diametric Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$7.6 - $10.53 $54,150 - $75,026	-7,125 Reduced 30.43%	16,287 $171,000
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $154,089 - $219,820	-21,551 Reduced 47.93%	23,412 $213,000
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $325,082 - $473,010	44,963 New	44,963 $326,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.